The present invention relates to novel compounds that are inhibitors of wild type and mutant dihydrofolate reductase (DHFR) of Plasmodium falciparum, which are useful for the treatment of malaria. It also relates to processes of making and using such compounds. The antimalarial compounds of the present invention have low toxicity to a host infected with the malarial parasite, and are potent when administered in pharmaceutical compositions.
[EN] ANTIMALARIAL COMPOUNDS WITH FLEXIBLE SIDE-CHAINS<br/>[FR] COMPOSÉS ANTIMALARIENS À CHAÎNE LATÉRALES FLEXIBLES
申请人:MEDICINES MALARIA VENTURE MMV
公开号:WO2009048957A1
公开(公告)日:2009-04-16
The present invention relates to novel compounds that are inhibitors of wild type and mutant dihydrofolate reductase (DHFR) of Plasmodium falciparum, which are useful for the treatment of malaria. It also relates to processes of making and using such compounds. The antimalarial compounds of the present invention have low toxicity to a host infected with the malarial parasite, and are potent when administered in pharmaceutical compositions.
ANTIMALARIAL COMPOUNDS WITH FLEXIBLE SIDE-CHAINS
申请人:YUTHAVONG Yongyuth
公开号:US20090099220A1
公开(公告)日:2009-04-16
The present invention relates to novel compounds that are inhibitors of wild type and mutant dihydrofolate reductase (DHFR) of
Plasmodium falciparum
, which are useful for the treatment of malaria. It also relates to processes of making and using such compounds. The antimalarial compounds of the present invention have low toxicity to a host infected with the malarial parasite, and are potent when administered in pharmaceutical compositions.